Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 67,236 shares at $1.92 ($129K) on 2016-05-26, disclosed to the SEC on 2016-05-31.
Open-market sale of $129k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.92 | 27,168 | $52K | 40.4% |
| 2 | $1.92 | 27,168 | $52K | 40.4% |
| 3 | $1.93 | 12,700 | $25K | 19.0% |
| 4 | $1.94 | 200 | $388 | 0.3% |
| Total | $1.92 avg | 67,236 | $129K | 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |